Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Biological Systems (1)
- Biology and Environment (51)
- Biology and Soft Matter (1)
- Clean Energy (33)
- Climate and Environmental Systems (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (5)
- Materials (24)
- Materials for Computing (4)
- National Security (15)
- Neutron Science (8)
- Nuclear Science and Technology (5)
- Quantum information Science (2)
- Supercomputing (47)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.